Search

Your search keyword '"Wenlei Jiang"' showing total 99 results

Search Constraints

Start Over You searched for: Author "Wenlei Jiang" Remove constraint Author: "Wenlei Jiang" Language undetermined Remove constraint Language: undetermined
99 results on '"Wenlei Jiang"'

Search Results

1. Generic lamotrigine extended‐release tablets are bioequivalent to innovator drug in fully replicated crossover bioequivalence study

2. iBCS: 2. Mechanistic Modeling of Pulmonary Availability of Inhaled Drugs versus Critical Product Attributes

3. iBCS: 1. Principles and Framework of an Inhalation-Based Biopharmaceutics Classification System

4. In Vitro Matured Human Pluripotent Stem Cell–Derived Cardiomyocytes Form Grafts With Enhanced Structure and Function in Injured Hearts

5. Considerations for the Forced Expiratory Volume in 1 Second‐Based Comparative Clinical Endpoint Bioequivalence Studies for Orally Inhaled Drug Products

6. SNRPB promotes cell cycle progression in thyroid carcinoma via inhibiting p53

7. Research and Education Needs for Complex Generics

8. Challenges and opportunities in the development of complex generic long-acting injectable drug products

9. Evaluation of the Physicochemical Properties of the Iron Nanoparticle Drug Products: Brand and Generic Sodium Ferric Gluconate

10. Preferences for and Experiences With Pill Appearance Changes: National Surveys of Patients and Pharmacists

12. Development of In Vitro Dissolution Testing Methods to Simulate Fed Conditions for Immediate Release Solid Oral Dosage Forms

13. Analysis of phospholipids and triacylglycerols in intravenous lipid emulsions

14. Lack of association between generic brittleness and neuropsychiatric measures in patients with epilepsy

15. Effects of Dissolution Medium pH and Simulated Gastrointestinal Contraction on Drug Release From Nifedipine Extended-Release Tablets*

16. Snapshots of Iron Speciation: Tracking the Fate of Iron Nanoparticle Drugs via a Liquid Chromatography–Inductively Coupled Plasma–Mass Spectrometric Approach

17. A Survey of Patients’ Perceptions of Pill Appearance and Responses to Changes in Appearance for Four Chronic Disease Medications

18. Exploring generic brittleness and the demographic factors for its susceptibility in patients with epilepsy

19. Analysis of verteporfin liposomal formulations for phospholipids and phospholipid degradation products by liquid chromatography-mass spectrometry (LC-MS)

20. The Global Bioequivalence Harmonisation Initiative (GBHI): Report of EUFEPS/AAPS fourth conference

21. Abstract 307: Lymph node accumulation of theranostic lipid-based nanoparticles in healthy and diseased models: Preliminary results comparing nanoparticle morphology and targeting

22. IntegratingIn Vitro, Modeling, andIn VivoApproaches to Investigate Warfarin Bioequivalence

23. In Vitro Evaluation of Nasogastric Tube Delivery Performance of Esomeprazole Magnesium Delayed-Release Capsules

24. Dissolution Failure of Solid Oral Drug Products in Field Alert Reports

25. Equivalence of complex drug products: advances in and challenges for current regulatory frameworks

26. Outcomes Associated with Generic Drugs Approved Using Product-Specific Determinations of Therapeutic Equivalence

27. Tailored theranostic apolipoprotein E3 porphyrin-lipid nanoparticles target glioblastoma

28. Lack of Association of Generic Brittle Status with Genetics and Physiologic Measures in Patients with Epilepsy

29. Quantification of phospholipid degradation products in liposomal pharmaceutical formulations by ultra performance liquid chromatography-mass spectrometry (UPLC-MS)

30. The global bioequivalence harmonisation initiative: Report of EUFEPS/AAPS third conference

31. Quantitative analysis of cholesterol oxidation products and desmosterol in parenteral liposomal pharmaceutical formulations

32. Report of the AAPS Guidance Forum on the FDA Draft Guidance for Industry: 'Drug Products, Including Biological Products, that Contain Nanomaterials'

33. An in vitro approach for evaluating the oral abuse deterrence of solid oral extended-release opioids with properties intended to deter abuse via chewing

34. Therapeutic Drug Monitoring, Electronic Health Records, and Pharmacokinetic Modeling to Evaluate Sirolimus Drug Exposure–Response Relationships in Renal Transplant Patients

35. Switch-backs associated with generic drugs approved using product-specific determinations of therapeutic equivalence

36. Effect of Common Excipients on the Oral Drug Absorption of Biopharmaceutics Classification System Class 3 Drugs Cimetidine and Acyclovir

37. Web-based digital twin modeling and remote control of cyber-physical production systems

38. Relationship of antiepileptic drugs to generic brittleness in patients with epilepsy

39. Assessment of tacrolimus intrapatient variability in stable adherent transplant recipients: Establishing baseline values

40. Evaluation of Switching Patterns in FDA's Sentinel System: A New Tool to Assess Generic Drugs

41. Development of a flow-through USP 4 apparatus drug release assay for the evaluation of amphotericin B liposome

42. Direct quantification of unencapsulated doxorubicin in liposomal doxorubicin formulations using capillary electrophoresis

43. A PEGylation-Free Biomimetic Porphyrin Nanoplatform for Personalized Cancer Theranostics

44. Release of levetiracetam from extended-release tablets that appear intact in patient stool

45. Reply to 'On the Effect of Common Excipients on the Oral Absorption of Class 3 Drugs'

46. Comparative Evaluation of U.S. Brand and Generic Intravenous Sodium Ferric Gluconate Complex in Sucrose Injection: Biodistribution after Intravenous Dosing in Rats

47. In vitro and in vivo DFO-chelatable labile iron release profiles among commercially available intravenous iron nanoparticle formulations

48. Risk-Based Bioequivalence Recommendations for Antiepileptic Drugs

49. Generic Versions of Narrow Therapeutic Index Drugs: A National Survey of Pharmacists' Substitution Beliefs and Practices

50. Dissolution Test of Tacrolimus Capsule: Effects of Filtration and Glass Adsorption

Catalog

Books, media, physical & digital resources